Trials / Unknown
UnknownNCT02292043
Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Harbin Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.
Detailed description
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization would also calculated 3 months after discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HTEA | HTEA |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2014-11-17
- Last updated
- 2014-11-17
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02292043. Inclusion in this directory is not an endorsement.